The Food and Drug Administration has approved the drug PrEP, also known as Truvada, for adolescents. In an anniuncement released this week, the government health agency recommended that the daily treatment be…

You pretty much know the facts when it comes to HIV, right? Well, you might be falsely confident: A study of almost 2,000 people published in BMC Public Health found that almost half had…

The number of people taking PrEP in the United States is steadily increasing, exceeding 77,000 in 2016, according to figures released yesterday by AIDSVu in conjunction with the 25th Conference on…

Despite advances in the treatment and prevention of HIV, many barriers still block African Americans and people of color from getting the health care they need. When it comes to HIV, that's…

Florida health officials say the department plans to offer HIV prevention drug PrEP for free throughout the state by the end of 2018. Florida's rate of new HIV diagnoses is more…

Researchers at Massachusetts Institute of Technology and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose.  Researchers say…

A new Drexel University study has determined that the US could reach its 2020 HIV prevention goal to prevent 30% of new HIV infections if just 25% of men who have…

Gilead Sciences, Inc.,  a research-based biopharmaceutical company announced the launch of the Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative today. The initiative is a 10-year, $100 million commitment to…

If you’re confused about HIV and what viral suppression means, you’re not alone. The National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID) recently published a blog post entitled…

The University of Texas at Dallas will be hosting the 2017 HIV/AIDS Awareness Week November 27 - December 1, leading up to World AIDS Day on December 1st. HIV/AIDS Awareness Week will focus…